Fig. 2: LS mean change from baseline at each time point (mITT population). | npj Schizophrenia

Fig. 2: LS mean change from baseline at each time point (mITT population).

From: Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation

Fig. 2

a PANSS total score, where mean PANSS score at baseline for placebo = 96.4 (SD: 7.21), for Risperidone ISM 75 mg = 96.3 (SD: 8.47) and for Risperidone ISM 100 mg = 96.1 (SD: 8.42). The error bars represent SE and P values are for Risperidone ISM 75 mg and Risperidone ISM 100 mg dose group versus placebo (*p < 0.01, **p < 0.001, ***p < 0.0001), in b CGI-S Score, where mean CGI-S score at baseline for placebo = 4.9 (SD: 0.54), Risperidone ISM 75 mg = 4.9 (SD: 0.63) and Risperidone ISM 100 mg = 4.8 (SD: 0.53). The error bars represent SE and P values are for Risperidone ISM 75 mg and Risperidone ISM 100 mg dose group versus placebo (*p < 0.01, **p < 0.0001).

Back to article page